Unicycive Therapeutics, Inc. (UNCY) Free cash flow 2021–2025
Unicycive Therapeutics, Inc. (UNCY) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$31.3MFY2025 · since FY2021: -$5.8M → -$31.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$31.3M | -9.4% |
| FY2024 | -$28.6M | -56.6% |
| FY2023 | -$18.3M | -16.9% |
| FY2022 | -$15.7M | -170.1% |
| FY2021 | -$5.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice